Intermittent fasting with hormone therapy for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether intermittent fasting (alternating between eating and not eating for certain periods) can help men with prostate cancer who are receiving hormone therapy (androgen deprivation therapy). It aims to see if fasting during treatment can reduce side effects or improve how well the therapy works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and male at birth.
- You must have measurable prostate cancer and be eligible for hormone therapy.
- You must be able to do your daily activities with little to no help (ECOG score 0-2).
- Your major organs (like kidneys, liver, and blood counts) need to be working well enough, based on blood tests.
- You must either have a stored tumor sample or be willing to have a new biopsy before starting treatment.
- You cannot be getting treatment for another cancer or have an allergy to the dye used for CT/MRI scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a 7-day water-only fast or taking ketone supplements can help treat prostate cancer. You would have a biopsy before and after to see how the tumor responds.
This trial studies whether a structured lifestyle intervention (such as exercise and related behavior changes) can benefit people with metastatic prostate cancer who are currently on hormone treatment. It may help by improving health and functioning while you continue standard cancer therapy.
This pilot study tests whether alternating periods of lower calorie intake, along with a plant-based diet, is safe and feasible for people receiving chemotherapy. If it helps, it could support better comfort and treatment tolerance during cancer therapy.
This trial studies whether a 14-hour night fast and 10-hour eating window can improve inflammation markers and quality of life in women with HR+/HER2- early breast cancer. You would start the fasting routine within three months of beginning hormone therapy.
This study tests whether periods of fasting (eating very little for set times) combined with immunotherapy drugs might help treat advanced cancers like lung, stomach, liver, or melanoma. The goal is to see if fasting helps the immune-boosting drugs work better.
This trial tests whether an intermittent, fasting-like diet can help control metastatic prostate cancer and improve metabolic health in men on hormone therapy. Participants follow a specific diet plan and are monitored by the study team.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.